NASDAQ:LQDA - Liquidia Technologies Stock Price, News & Analysis

-0.08 (-1.94 %)
(As of 09/15/2019 10:00 AM ET)
Today's Range
Now: $4.05
50-Day Range
MA: $5.68
52-Week Range
Now: $4.05
Volume1,044 shs
Average Volume100,393 shs
Market Capitalization$75.49 million
P/E RatioN/A
Dividend YieldN/A
Liquidia Technologies, Inc, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865, which completed Phase 1 clinical trials for the treatment of local post-operative pain. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:LQDA



Sales & Book Value

Annual Sales$2.71 million
Book Value$1.21 per share


Net Income$-53,140,000.00
Net Margins-1,962.91%


Market Cap$75.49 million
Next Earnings Date10/30/2019 (Estimated)
OptionableNot Optionable

Receive LQDA News and Ratings via Email

Sign-up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter.

Liquidia Technologies (NASDAQ:LQDA) Frequently Asked Questions

What is Liquidia Technologies' stock symbol?

Liquidia Technologies trades on the NASDAQ under the ticker symbol "LQDA."

How were Liquidia Technologies' earnings last quarter?

Liquidia Technologies Inc (NASDAQ:LQDA) posted its quarterly earnings data on Thursday, August, 8th. The company reported ($0.32) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.57) by $0.25. The company earned $8.07 million during the quarter, compared to analyst estimates of $0.69 million. Liquidia Technologies had a negative return on equity of 134.64% and a negative net margin of 1,962.91%. View Liquidia Technologies' Earnings History.

When is Liquidia Technologies' next earnings date?

Liquidia Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for Liquidia Technologies.

What price target have analysts set for LQDA?

4 analysts have issued twelve-month price objectives for Liquidia Technologies' shares. Their predictions range from $27.00 to $50.00. On average, they expect Liquidia Technologies' stock price to reach $37.25 in the next year. This suggests a possible upside of 819.8% from the stock's current price. View Analyst Price Targets for Liquidia Technologies.

What is the consensus analysts' recommendation for Liquidia Technologies?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Liquidia Technologies in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Liquidia Technologies.

What are Wall Street analysts saying about Liquidia Technologies stock?

Here are some recent quotes from research analysts about Liquidia Technologies stock:
  • 1. According to Zacks Investment Research, "Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company. It focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. The company's product candidate consists of LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain which are in clinical stage. Liquidia Technologies, Inc. is based in NC, United States. " (8/14/2019)
  • 2. Wedbush analysts commented, "We base our $27 price target on a sum-of-the-parts analysis derived from: (1) the P/E value of La Jolla’s current commercial business (Giapreza); (2) an NPV of its pipeline (LJPC-401); and (3) our estimated year-end 2019 fully diluted net cash of $2.03/share to arrive at our price target. We value the current commercial business at $12.94 per share and the pipeline at $11.99 per share. The commercial business value is based on a P/E multiple assumption of 30x our 2024E EPS of $0.75, discounted at 15%." (6/28/2019)

Has Liquidia Technologies been receiving favorable news coverage?

News stories about LQDA stock have trended somewhat positive recently, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Liquidia Technologies earned a news sentiment score of 0.9 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Liquidia Technologies.

Are investors shorting Liquidia Technologies?

Liquidia Technologies saw a drop in short interest in August. As of August 31st, there was short interest totalling 315,900 shares, a drop of 22.2% from the July 31st total of 406,000 shares. Based on an average trading volume of 76,200 shares, the days-to-cover ratio is currently 4.1 days. Currently, 4.6% of the company's stock are sold short. View Liquidia Technologies' Current Options Chain.

Who are some of Liquidia Technologies' key competitors?

What other stocks do shareholders of Liquidia Technologies own?

Who are Liquidia Technologies' key executives?

Liquidia Technologies' management team includes the folowing people:
  • Mr. Neal F. Fowler, CEO & Director (Age 57)
  • Mr. Robert A. Lippe, Chief Operations Officer (Age 54)
  • Mr. William R. Kenan Jr., Co-Founder
  • Dr. Ginger Denison, Co-Founder
  • Mr. Timothy M. Albury, Interim Chief Financial Officer (Age 50)

When did Liquidia Technologies IPO?

(LQDA) raised $50 million in an initial public offering on Thursday, July 26th 2018. The company issued 4,500,000 shares at a price of $10.00-$12.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers.

Who are Liquidia Technologies' major shareholders?

Liquidia Technologies' stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (4.47%), Samsara BioCapital LLC (3.53%), Vanguard Group Inc. (2.48%), Northern Trust Corp (0.46%), OZ Management LP (0.43%) and Citadel Advisors LLC (0.32%). Company insiders that own Liquidia Technologies stock include Arthur S Kirsch, Benjamin Maynor, Kevin K Gordon, Plc Glaxosmithkline, Timothy Albury and Viii Lp Canaan. View Institutional Ownership Trends for Liquidia Technologies.

Which institutional investors are selling Liquidia Technologies stock?

LQDA stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC and OZ Management LP. Company insiders that have sold Liquidia Technologies company stock in the last year include Benjamin Maynor, Kevin K Gordon and Timothy Albury. View Insider Buying and Selling for Liquidia Technologies.

Which institutional investors are buying Liquidia Technologies stock?

LQDA stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., Samsara BioCapital LLC, Keel Point LLC, Charles Schwab Investment Management Inc., Northern Trust Corp, Bank of New York Mellon Corp and Wells Fargo & Company MN. Company insiders that have bought Liquidia Technologies stock in the last two years include Arthur S Kirsch, Plc Glaxosmithkline and Viii Lp Canaan. View Insider Buying and Selling for Liquidia Technologies.

How do I buy shares of Liquidia Technologies?

Shares of LQDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Liquidia Technologies' stock price today?

One share of LQDA stock can currently be purchased for approximately $4.05.

How big of a company is Liquidia Technologies?

Liquidia Technologies has a market capitalization of $75.49 million and generates $2.71 million in revenue each year. The company earns $-53,140,000.00 in net income (profit) each year or ($7.51) on an earnings per share basis. View Additional Information About Liquidia Technologies.

What is Liquidia Technologies' official website?

The official website for Liquidia Technologies is

How can I contact Liquidia Technologies?

Liquidia Technologies' mailing address is 419 DAVIS DRIVE SUITE 100, MORRISVILLE NC, 27560. The company can be reached via phone at 919-328-4400 or via email at [email protected]

MarketBeat Community Rating for Liquidia Technologies (NASDAQ LQDA)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  97 (Vote Outperform)
Underperform Votes:  111 (Vote Underperform)
Total Votes:  208
MarketBeat's community ratings are surveys of what our community members think about Liquidia Technologies and other stocks. Vote "Outperform" if you believe LQDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LQDA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/15/2019 by Staff

Featured Article: Strike Price

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel